Accurate determination of mean ionization potential (Im) has the potential to reduce range uncertainty based margins and therefore allow for more focal treatments in proton radiotherapy. Many methods have been proposed to reduce uncertainty in Im and stopping power ratios (SPR) each with varying degrees of accuracy and issues. In this work, we present on a simple parameterized model to determine Im in human biological tissue, which allows for computation of patient-specific Im at the voxel level using magnetic resonance imaging (MRI). The model requires the measurement of three parameters by MRI with only two parameters, mass percent water content and mass percent hydrogen content in organic molecules, required for the special case of soft tissues. The accuracy of this Im determination method was evaluated in available "standard" (ICRU Report #44) human tissues. The sensitivity of this Im determination method to in-vivo perturbations was also tested by calculating the effect of 10% variations of the experimentally measurable parameters on Im and SPR. For the human tissues modeled in this work, a high level of accuracy with low susceptibility to perturbations in measurement error was achieved in the prediction of Im. Root-mean-square errors (RMSE) in Im were within 0.77% and 1.8% for both soft and bony tissues and were 0.09% and 0.2% for soft and bony tissues SPR, respectively, assuming knowledge of electron density.Proof of principle MR measurements and model-based computations of Im and SPR were taken in phantom for a series of hydrogenous solutions and compared against expected Im and SPR calculations from known elemental composition. MR determined Im and SPR values in a known composition solution were determined to within 5% and 0.52%, respectively. We present on a novel model to accurately calculate mean ionization potential from measurements acquirable by MRI and show feasibility in phantom.